EVIO Labs Berkeley Announces ISO 17025 Accreditation
Original story from EVIO Labs
EVIO has announced that its Northern California laboratory in Berkeley, CA, C3 Labs, has attained ISO 17025 accreditation (Accreditation #99861, Certificate #L18-256) from Perry Johnson Laboratory Accreditation (PJLA). ISO 17025 accreditation is the highest recognized quality standard in the world for calibration and testing laboratories.
For an organization to be accredited in ISO 17025, its laboratory must be able to consistently produce precise and accurate tests for cannabinoids, pesticides, and contaminants, and have implemented a rigorous quality management system. The accreditation also requires personnel to have met specific academic and training credentials.
"EVIO is committed to upholding the highest standards throughout each step of the testing process and we are extremely pleased with the team's hard work to reach this great achievement," said Ron Russak, Vice President of Operations, EVIO Labs. "As the California cannabis industry evolves and state-mandated laboratory standards of operation prove vital, both clients and consumers will now have assurance that the results will be accurate and reliable."
According to California's Bureau of Cannabis Control, beginning July 1, a licensee may only sell cannabis goods that have been tested and passed all testing requirements in effect at the time of testing. EVIO Labs Berkeley is well-positioned to meet the increase demand for analytical testing services for regulated cannabis and is prepared for these heightened regulations.
"As the California cannabis industry matures, focus has shifted heavily towards ensuring consumer safety," said Lori Glauser, COO of EVIO Labs. "Since the Company's conception, the team has been hyper-focused on building the infrastructure to keep up with heightened quality standards and regulations imminent for every legal cannabis market. EVIO has a pivotal role to help ensure the health and safety of the product which will give consumers peace of mind."
EVIO acquired C3 Labs in January 2018. C3 Labs has been serving the cannabis industry since 2015. C3 Labs has been issued a Cannabis Research and Development business license by the City of Berkeley that permits them to provide cannabis scientific research, product design, development and testing. C3 Labs was one of the nation's first, true, cannabis-focused contract research organization (CRO), with both field services and a state of the art research center. C3 Labs' highly experienced scientists and engineers utilize cutting edge technology to support their customers in analytical chemistry, process chemistry, formulations, and engineering.